ViewRay (NASDAQ:VRAY) Downgraded by Zacks Investment Research
According to Zacks, “ViewRay Inc. is a medical ... group, research analysts anticipate that ViewRay will post -0.6 EPS for the current fiscal year. In other news, Director Caley Castelein bought ...